TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biovica International AB
Closing information (x1000 DKK)
| Closing information | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Turnover |
5,863
|
4,626
|
2,227 |
| Financial expenses |
775
|
183
|
325 |
| Earnings before taxes |
-58,492
|
-78,775
|
-72,857 |
| EBITDA |
-52,378
|
-74,511
|
-67,303 |
| Total assets |
44,183
|
83,390
|
113,411 |
| Current assets |
20,948
|
55,917
|
78,985 |
| Current liabilities |
12,352
|
17,953
|
15,560 |
| Equity capital |
29,392
|
61,327
|
91,259 |
| - share capital |
4,435
|
3,556
|
2,007 |
| Employees (average) |
26
|
37
|
31 |
Financial ratios
| Fiscal year | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Solvency |
66.5%
|
73.5%
|
80.5% |
| Turnover per employee |
226
|
125
|
72 |
| Profit as a percentage of turnover |
-997.6%
|
-1702.9%
|
-3271.5% |
| Return on assets (ROA) |
-130.6%
|
-94.2%
|
-64.0% |
| Current ratio |
169.6%
|
311.5%
|
507.6% |
| Return on equity (ROE) |
-199.0%
|
-128.5%
|
-79.8% |
| Change turnover |
904
|
2,479
|
881 |
| Change turnover % |
18%
|
115%
|
65% |
| Chg. No. of employees |
-11
|
6
|
6 |
| Chg. No. of employees % |
-30%
|
19%
|
24% |
Total value of public sale
| Fiscal year | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.